ATF4P2

Across TCGA pan-cancer cohorts, ATF4P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ATF4P2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where ATF4P2 RNA is repressed in tumor relative to normal tissue. In most cancer types ATF4P2 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD and KIRC are the cancer types where ATF4P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATF4P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	III,IV	−0.048	.007	1	view →
KIRC	Female	All	+0.019	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

ATF4P2–STAD

Open the STAD breakdown →